SNDL
SNDL
NASDAQ · Pharmaceuticals

Sndl Inc

$1.42
-0.02 (-1.39%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +1,037.3% upside
Low Target $10.52
Average Target $16.15
High Target $19.28
Current Price $1.42
Current
$1.42
Target
$16.15
$10.52 $16.15 avg $19.28
Scenario Analysis
Bear Case
$10.52
640.8%
Low target
Base Case
$16.15
+1,037.3%
Avg target
Bull Case
$19.28
+1,257.7%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$2.89
-50.9% from high
52-Week Low
$1.15
+23.5% from low
Target vs 52W High
$16.15
+458.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +18.3%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +22.2%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +27.7%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +42.3%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +170.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%